
News|Videos|November 1, 2023
Overcoming Barriers to Triplet Therapy in Prostate Cancer
Author(s)David Morris, MD, FACS, Benjamin Garmezy, MD
Join experts David Morris, MD, FACS, and Benjamin Garmezy, MD, as they discuss the barriers and considerations in prescribing triplet therapy, offering insight into its benefits and how collaborative care between urologists and medical oncologists ensures a seamless patient journey.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves Titan Prime Inflatable Penile Prosthesis
2
Enzalutamide associated with greater cognitive decline than darolutamide in advanced prostate cancer
3
FDA approves cefepime and zidebactam for complicated UTI
4
Phase 1 AcTION trial establishes RP2D for 225Ac-PSMA-617
5
















